Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chase Co. stock logo
CCF
Chase
$127.49
$0.00
$81.18
$135.27
$1.21B0.6884,837 shsN/A
Essentra plc stock logo
FLRAF
Essentra
$2.42
$2.16
$1.90
$2.55
$730.09M-0.725 shsN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.69
-0.5%
C$5.50
C$4.35
C$5.95
C$575.66M0.4973,492 shs59,090 shs
Enpro Inc. stock logo
NPO
Enpro
$149.78
-0.8%
$158.70
$92.04
$170.63
$3.14B1.5597,135 shs87,771 shs
TPI Composites, Inc. stock logo
TPIC
TPI Composites
$2.39
-3.2%
$2.79
$1.63
$12.53
$113.45M2.031.14 million shs1.18 million shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chase Co. stock logo
CCF
Chase
0.00%0.00%0.00%0.00%+22.00%
Essentra plc stock logo
FLRAF
Essentra
0.00%0.00%+12.56%+20.40%-5.10%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-1.72%-2.39%+8.95%+3.81%+19.42%
Enpro Inc. stock logo
NPO
Enpro
-0.19%-0.66%-5.59%-4.98%+58.11%
TPI Composites, Inc. stock logo
TPIC
TPI Composites
-4.63%-9.85%-8.86%-12.41%-80.08%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Chase Co. stock logo
CCF
Chase
N/AN/AN/AN/AN/AN/AN/AN/A
Essentra plc stock logo
FLRAF
Essentra
N/AN/AN/AN/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
0.7779 of 5 stars
2.50.00.00.00.03.30.6
Enpro Inc. stock logo
NPO
Enpro
2.0352 of 5 stars
0.02.01.71.43.22.51.9
TPI Composites, Inc. stock logo
TPIC
TPI Composites
3.753 of 5 stars
3.11.00.04.43.51.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chase Co. stock logo
CCF
Chase
N/AN/AN/AN/A
Essentra plc stock logo
FLRAF
Essentra
3.00
BuyN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.00
BuyC$6.5815.70% Upside
Enpro Inc. stock logo
NPO
Enpro
N/AN/A$158.005.49% Upside
TPI Composites, Inc. stock logo
TPIC
TPI Composites
2.11
Hold$9.22285.87% Upside

Current Analyst Ratings

Latest CCF, TPIC, NPO, GUD, and FLRAF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$6.50 ➝ C$7.00
3/6/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$7.00 ➝ C$7.50
2/28/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperformC$7.00
2/23/2024
TPI Composites, Inc. stock logo
TPIC
TPI Composites
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$4.00 ➝ $3.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chase Co. stock logo
CCF
Chase
$404.02M3.00$7.41 per share17.20$42.94 per share2.97
Essentra plc stock logo
FLRAF
Essentra
$393.33M1.86$0.27 per share9.09$1.66 per share1.46
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$328.20M1.75C$1.48 per share3.85C$7.38 per share0.77
Enpro Inc. stock logo
NPO
Enpro
$1.06B2.96$13.84 per share10.82$67.43 per share2.22
TPI Composites, Inc. stock logo
TPIC
TPI Composites
$1.46B0.08N/AN/A($2.87) per share-0.83

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chase Co. stock logo
CCF
Chase
$33.18M$3.4836.64N/A8.21%10.54%6.63%N/A
Essentra plc stock logo
FLRAF
Essentra
$6.72MN/A0.0013.44N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$16.84M-C$0.16N/AN/A-5.13%-2.14%0.40%5/9/2024 (Estimated)
Enpro Inc. stock logo
NPO
Enpro
$22.20M$1.06141.3018.65N/A2.10%9.67%5.32%5/7/2024 (Confirmed)
TPI Composites, Inc. stock logo
TPIC
TPI Composites
-$201.78M-$4.18N/AN/AN/A-8.19%N/A-12.66%5/2/2024 (Confirmed)

Latest CCF, TPIC, NPO, GUD, and FLRAF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Enpro Inc. stock logo
NPO
Enpro
$1.54N/A-$1.54N/AN/AN/A  
5/2/2024N/A
TPI Composites, Inc. stock logo
TPIC
TPI Composites
-$0.66N/A+$0.66N/AN/AN/A  
3/21/2024Q4 2023
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$0.02-C$0.03-C$0.05C$0.17C$78.37 millionC$74.20 million
2/22/2024Q4 2023
TPI Composites, Inc. stock logo
TPIC
TPI Composites
-$0.91$0.27+$1.18$0.23$340.91 million$296.99 million    
2/20/202412/31/2023
Enpro Inc. stock logo
NPO
Enpro
$1.47$1.19-$0.28$2.61$264.10 million$241.90 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Chase Co. stock logo
CCF
Chase
$1.000.78%N/A28.74%N/A
Essentra plc stock logo
FLRAF
Essentra
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
Enpro Inc. stock logo
NPO
Enpro
$1.200.80%+3.71%113.21%9 Years
TPI Composites, Inc. stock logo
TPIC
TPI Composites
N/AN/AN/AN/AN/A

Latest CCF, TPIC, NPO, GUD, and FLRAF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2024
Enpro Inc. stock logo
NPO
Enpro
quarterly$0.300.7%3/5/20243/6/20243/20/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chase Co. stock logo
CCF
Chase
0.26
4.44
2.77
Essentra plc stock logo
FLRAF
Essentra
N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
9.25
3.20
1.79
Enpro Inc. stock logo
NPO
Enpro
0.45
3.31
2.59
TPI Composites, Inc. stock logo
TPIC
TPI Composites
N/A
1.30
1.28

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Chase Co. stock logo
CCF
Chase
87.10%
Essentra plc stock logo
FLRAF
Essentra
N/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
13.67%
Enpro Inc. stock logo
NPO
Enpro
98.31%
TPI Composites, Inc. stock logo
TPIC
TPI Composites
75.24%

Insider Ownership

CompanyInsider Ownership
Chase Co. stock logo
CCF
Chase
13.70%
Essentra plc stock logo
FLRAF
Essentra
N/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
46.45%
Enpro Inc. stock logo
NPO
Enpro
1.60%
TPI Composites, Inc. stock logo
TPIC
TPI Composites
4.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Chase Co. stock logo
CCF
Chase
8599.52 million8.22 millionNot Optionable
Essentra plc stock logo
FLRAF
Essentra
3,209301.69 millionN/ANot Optionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
725101.17 millionN/ANot Optionable
Enpro Inc. stock logo
NPO
Enpro
3,50020.94 million20.61 millionOptionable
TPI Composites, Inc. stock logo
TPIC
TPI Composites
12,30047.47 million45.19 millionOptionable

CCF, TPIC, NPO, GUD, and FLRAF Headlines

SourceHeadline
TPI Composites (TPIC) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseTPI Composites (TPIC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
zacks.com - April 25 at 11:06 AM
TPI Composites (TPIC) Scheduled to Post Earnings on ThursdayTPI Composites (TPIC) Scheduled to Post Earnings on Thursday
americanbankingnews.com - April 25 at 2:47 AM
TPI Composites, Inc. (NASDAQ:TPIC) Given Consensus Recommendation of "Hold" by AnalystsTPI Composites, Inc. (NASDAQ:TPIC) Given Consensus Recommendation of "Hold" by Analysts
americanbankingnews.com - April 23 at 2:32 AM
TPI Composites, Inc. (NASDAQ:TPIC) Given Average Recommendation of "Hold" by AnalystsTPI Composites, Inc. (NASDAQ:TPIC) Given Average Recommendation of "Hold" by Analysts
marketbeat.com - April 23 at 2:29 AM
TPI Composites, Inc. Announces First Quarter 2024 Earnings Release Date and Conference CallTPI Composites, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
globenewswire.com - April 11 at 4:05 PM
Edward Hall nominated to join the board of directors of TPI CompositesEdward Hall nominated to join the board of directors of TPI Composites
windtech-international.com - April 10 at 7:44 AM
Edward Hall Nominated to Join the Board of Directors of TPI Composites, Inc.Edward Hall Nominated to Join the Board of Directors of TPI Composites, Inc.
globenewswire.com - April 9 at 4:05 PM
TPI Composites, Inc. (NASDAQ:TPIC) is a favorite amongst institutional investors who own 69%TPI Composites, Inc. (NASDAQ:TPIC) is a favorite amongst institutional investors who own 69%
finance.yahoo.com - April 6 at 10:48 AM
TPI Composites, Inc. (NASDAQ:TPIC) Given Average Rating of "Hold" by BrokeragesTPI Composites, Inc. (NASDAQ:TPIC) Given Average Rating of "Hold" by Brokerages
marketbeat.com - March 29 at 2:30 AM
TPI Composites, Inc. Publishes its Annual Sustainability Report Reaffirming Its Commitments to a Zero-Harm Culture and Carbon NeutralityTPI Composites, Inc. Publishes its Annual Sustainability Report Reaffirming Its Commitments to a Zero-Harm Culture and Carbon Neutrality
globenewswire.com - March 28 at 4:05 PM
TPI Composites files patent for composite structure fabrication method using magnetic anchors and optical markersTPI Composites files patent for composite structure fabrication method using magnetic anchors and optical markers
power-technology.com - March 27 at 12:03 AM
TPI Composites IncTPI Composites Inc
money.usnews.com - March 23 at 12:16 AM
TPIC Apr 2024 2.500 callTPIC Apr 2024 2.500 call
finance.yahoo.com - March 16 at 2:16 PM
TPI Composites: Weak Results And GuidanceTPI Composites: Weak Results And Guidance
seekingalpha.com - March 1 at 12:40 PM
TPI Composites: Turnaround Is In Sight (Rating Upgrade)TPI Composites: Turnaround Is In Sight (Rating Upgrade)
seekingalpha.com - February 26 at 8:18 PM
Earnings Update: TPI Composites, Inc. (NASDAQ:TPIC) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: TPI Composites, Inc. (NASDAQ:TPIC) Just Reported And Analysts Are Trimming Their Forecasts
finance.yahoo.com - February 25 at 12:29 PM
TPI Composites Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagTPI Composites Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
finance.yahoo.com - February 24 at 10:40 AM
TPI Composites, Inc. (NASDAQ:TPIC) Q4 2023 Earnings Call TranscriptTPI Composites, Inc. (NASDAQ:TPIC) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 23 at 1:16 PM
Q4 2023 TPI Composites Inc Earnings CallQ4 2023 TPI Composites Inc Earnings Call
finance.yahoo.com - February 23 at 8:16 AM
TPI Composites: Transitioning Towards Long-Term Growth, Maintains Buy RatingTPI Composites: Transitioning Towards Long-Term Growth, Maintains Buy Rating
markets.businessinsider.com - February 23 at 2:19 AM
TPI Composites: Q4 Earnings InsightsTPI Composites: Q4 Earnings Insights
benzinga.com - February 22 at 9:18 PM
TPI Composites Inc (TPIC) Reports Mixed 2023 Financial Results Amidst Industry ChallengesTPI Composites Inc (TPIC) Reports Mixed 2023 Financial Results Amidst Industry Challenges
finance.yahoo.com - February 22 at 9:18 PM
Heres What Key Metrics Tell Us About TPI Composites (TPIC) Q4 EarningsHere's What Key Metrics Tell Us About TPI Composites (TPIC) Q4 Earnings
zacks.com - February 22 at 9:01 PM
TPI Composites (TPIC) Beats Q4 Earnings EstimatesTPI Composites (TPIC) Beats Q4 Earnings Estimates
zacks.com - February 22 at 8:51 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Chase logo

Chase

NYSEAMERICAN:CCF
Chase Corporation, a specialty chemicals company, engages in the manufacture and sale of protective materials for various applications in North America, Asia, the Middle East, Europe, and internationally. It operates through three segments: Adhesives, Sealants and Additives; Industrial Tapes; and Corrosion Protection and Waterproofing. The Adhesives, Sealants and Additives segment offers protective conformal and moisture protective electronic coatings and cleaning solutions; advanced adhesives, sealants, and coatings; polymeric microspheres; polyurethane dispersions; superabsorbent polymers; and cleaning and protection solutions for electronic assemblies. The Industrial Tapes segment provides wire and cable materials; specialty tapes and related products; insulating and conducting materials; laminated durable papers; water-blocking compounds; laminated film foils and cover tapes; and pulling and detection tapes. The Corrosion Protection and Waterproofing segment offers protective pipe-coating tapes and other protectants; polymeric asphalt additives; waterproofing membranes; waterproofing sealants, expansion joints, and accessories; technological products, and tapes and membranes; specialized high-performance coating and lining systems; waterproofing and corrosion protection systems; and pipeline protection tapes and products. It serves transportation, appliances, medical, general industrial, cable manufacturing, utilities and telecommunications, and electronics packaging markets, as well as oil companies, gas companies, and water/wastewater utilities. The company sells the products through its salespeople, as well as manufacturers' representatives and distributors. Chase Corporation was founded in 1946 and is headquartered in Westwood, Massachusetts.
Essentra logo

Essentra

OTCMKTS:FLRAF
Essentra plc manufactures and distributes plastic injection and vinyl dip moulded, and metal components worldwide. The company offers cable ties and conduit, and accessories; grommets, strain relief, and blanking plugs; cable glands and accessories; caps and plugs; card guides and pullers; circuit board hardware products; EMI suppression ferrite cores; fan accessories comprising filters and fan mounting accessories; screws and nuts; rivet and panel fasteners; washers; spacers; brushes; fleet; fibre management; and furniture fittings. It also provides gasketing, toggle clamps, and enclosure accessories; handles, knobs, and positioning components; masking tapes, hooks, and bags; hose clamps, O-rings and O-ring kits, and hose protection products; LED mounting, light pipes and lens; LED spacers; locks, latches, catches, and hinges; pipe and flange protection essentra products; tube inserts, connectors, and ferrules; and vibration mounts, dampers, and slide bearings, as well as handwheels. The company offers its products for a range of applications and industries that are used in protection and finish products. The company was formerly known as Filtrona plc and changed its name to Essentra plc in June 2013. Essentra plc was incorporated in 2005 and is based in Oxford, the United Kingdom.
Knight Therapeutics logo

Knight Therapeutics

TSE:GUD
Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.
Enpro logo

Enpro

NYSE:NPO
Enpro Inc. design, develops, manufactures, and markets proprietary, value-added products and solutions to safeguard critical environments in the United States, Europe, and internationally. It operates through two segments, Sealing Technologies and Advanced Surface Technologies. The Sealing Technologies segment offers single-use hygienic seals, tubing, components and assemblies; metallic, non-metallic, and composite material gaskets; dynamic seals; compression packing; hydraulic components; expansion joints; and wall penetration products for chemical and petrochemical processing, pulp and paper processing, nuclear energy, hydrogen, natural gas, food and biopharmaceutical processing, primary metal manufacturing, mining, water and waste treatment, commercial vehicle, aerospace, medical, filtration, and semiconductor fabrication industries. The Advanced Surface Technologies segment offers cleaning, coating, testing, refurbishment, and verification services for critical components and assemblies used in semiconductor manufacturing equipment, as well as for critical applications in the space, aerospace, and defense markets; and specialized optical filters and thin-film coatings for various applications in the industrial technology, life sciences, and semiconductor markets. The company was formerly known as EnPro Industries, Inc. and changed its name to Enpro Inc. in December 2023. Enpro Inc. was incorporated in 2002 and is headquartered in Charlotte, North Carolina.
TPI Composites logo

TPI Composites

NASDAQ:TPIC
TPI Composites, Inc. manufactures and sells composite wind blades, and related precision molding and assembly systems to original equipment manufacturers (OEMs) in the United States, Mexico, Europe, the Middle East, Africa, and India. It also provides composite solutions for the automotive industry; and field service inspection and repair services comprising diagnostic, repair, and maintenance services for wind blades to OEM customers, and wind farm owners and operators. The company was formerly known as LCSI Holding, Inc. and changed its name to TPI Composites, Inc. in 2008. TPI Composites, Inc. was founded in 1968 and is headquartered in Scottsdale, Arizona.